| Literature DB >> 11163229 |
I M de Alboran1, R C O'Hagan, F Gärtner, B Malynn, L Davidson, R Rickert, K Rajewsky, R A DePinho, F W Alt.
Abstract
Germline inactivation of c-myc in mice causes embryonic lethality. Therefore, we developed a LoxP/Cre-based conditional mutation approach to test the role of c-myc in mouse embryonic fibroblasts (MEFs) and mature B lymphocytes. Cre expression resulted in reduced proliferation of wild-type MEFs, but c-Myc-deficient MEFs showed a further reduction. In contrast to fibroblasts, Cre expression had no apparent affect on wild-type B cell proliferation. Deletion of both c-Myc genes in B cells led to severely impaired proliferation in response to anti-CD40 plus IL-4. However, treated cells did upregulate several early activation markers but not CD95 or CD95 ligand. We discuss these findings with respect to potential c-Myc functions in proliferation and apoptosis and also discuss potential limitations in the Cre-mediated gene inactivation approach.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11163229 DOI: 10.1016/s1074-7613(01)00088-7
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745